BALCAO · MEDICINAL CHEMICALS & BOTANICAL PRODUCTS · LARGE CAP
Curaleaf Holdings, Inc. CURLF
5 fiscal years on record · USD · FY2025 reported · SEC filings only
In brief
What this company does
Written from the business description in Curaleaf Holdings, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 27 February 2026. Every sentence was checked against that document before publication.
Growth
USD 1.3B
Revenue, FY2025 · full 5-year series below
Revenue $B
Net income $B
FY2025 · Revenue 1.3 · Net income -0.2
Compound annual growth
Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.
Profitability
−18 cents
lost on every revenue dollar
Operating margin
Net margin
FY2025 · Operating 2.0% · Net -18.0%
ROE
FY2025 · ROE -28.6%
Each USD of equity lost 29 cents this year.
The 5-year record
5 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue $B | 1.3 | 1.3 | 1.3 | 1.3 | 1.2 |
| Operating income $B | 0.0 | 0.0 | 0.0 | 0.1 | 0.1 |
| EBITDA $B | 0.2 | 0.3 | 0.2 | 0.2 | 0.2 |
| Income tax $B | 0.1 | 0.1 | 0.1 | 0.2 | 0.2 |
| Net income $B | −0.2 | −0.2 | −0.3 | −0.4 | −0.2 |
| Free cash flow $B | 0.1 | 0.1 | 0.0 | −0.1 | −0.2 |
| EPS, diluted $ | −0.35 | −0.32 | −0.39 | −0.52 | −0.29 |
| Dividend / sh $ | · | · | · | · | · |
| Payout % | · | · | · | · | · |
| ROE % | −28.6 | −22.5 | −24.1 | −26.2 | −13.3 |
| Shares out B | · | 0.75 | 0.73 | 0.72 | 0.71 |
Slide the table for earlier years · "·" marks a figure not available in our data for that year.
Compare
This company against its peers
Curaleaf Holdings, Inc.vsTrulieve Cannabis Corp.Same industry: Medicinal Chemicals & Botanical ProductsCuraleaf Holdings, Inc.vsTilray Brands, Inc.Same industry: Medicinal Chemicals & Botanical ProductsCuraleaf Holdings, Inc.vsNiagen Bioscience, Inc.Same industry: Medicinal Chemicals & Botanical ProductsCuraleaf Holdings, Inc.vsUsana Health Sciences Inc.Same industry: Medicinal Chemicals & Botanical ProductsCuraleaf Holdings, Inc.vsbiote Corp.Same industry: Medicinal Chemicals & Botanical ProductsCuraleaf Holdings, Inc.vsCronos Group Inc.Same industry: Medicinal Chemicals & Botanical ProductsCuraleaf Holdings, Inc.vsMediWound Ltd.Same industry: Medicinal Chemicals & Botanical Products
Provenance
Company facts, as filed
How we verify · 0 failures · 2 divergences in 25 reconciliationsAUDITED
Reconciled in 3 of 19 fiscal years. 2 of those reconciliations are divergences — the figures exist but don't fit the formula this check expects; that isn't the same as an error. 70 checks could not be computed.
EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures2 divergent
ActivityMedicinal Chemicals & Botanical Products
Listed onOTC market
Incorporated inoutside the United States — SEC code A1
Fiscal year endsDecember 31
Data on record since2021